Loading…
Veru Inc. is projected to rise to $2.40 by 2027, a +3% move from its current price of $2.33. VERU is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.28 | $2.33 | $2.39 | +0.04% |
| May 30 | $2.26 | $2.33 | $2.41 | +0.08% |
| May 31 | $2.24 | $2.33 | $2.43 | +0.12% |
| Jun 1 | $2.23 | $2.33 | $2.45 | +0.16% |
| Jun 2 | $2.22 | $2.33 | $2.46 | +0.19% |
| Jun 3 | $2.21 | $2.34 | $2.47 | +0.23% |
| Jun 4 | $2.20 | $2.34 | $2.49 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.20 | $2.34 | $2.49 | +0.27% |
| Week 2 | $2.15 | $2.34 | $2.56 | +0.55% |
| Week 3 | $2.11 | $2.35 | $2.62 | +0.82% |
| Week 4 | $2.08 | $2.36 | $2.67 | +1.10% |
| Week 5 | $2.06 | $2.36 | $2.71 | +1.37% |
| Week 6 | $2.03 | $2.37 | $2.76 | +1.65% |
| Week 7 | $2.02 | $2.37 | $2.80 | +1.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Veru Inc. is a healthcare company described as a late clinical stage biopharmaceutical company focused on developing medicines for metabolic diseases, oncology, and viral-induced ARDS in Florida and internationally. It provides the FC2 female condom for dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
The company develops enobosarm, a selective androgen receptor modulator for treatment of augmented fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral-induced ARDS and death.
Veru Inc. (VERU) is currently priced at $2.35. The stock sits in the small-cap space with a market capitalization of $37.72M and is ranked 4713. The current price and market position reflect a niche biotechnology focus within the healthcare space.
A major floor 17.7% below — a decisive break under it would weaken the trend.
The nearest floor, 10.3% below — buyers have tended to step in here.
The nearest ceiling, 6.0% above — a clean break opens room to run.
A major ceiling 20.2% above — clearing it would confirm fresh momentum.
Key VERU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VERU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.28 | Buy | $2.28 | Buy |
| MA 10 | $2.21 | Buy | $2.25 | Buy |
| MA 20 | $2.22 | Buy | $2.25 | Buy |
| MA 50 | $2.29 | Buy | $2.30 | Buy |
| MA 100 | $2.38 | Sell | $2.46 | Sell |
| MA 200 | $2.77 | Sell | $3.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.62 | Neutral |
| Stoch RSI (14) | 91.49 | Sell |
| CCI (20) | 123.89 | Buy |
| Williams %R (14) | -7.69 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 4.02 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 92.31 | Sell |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 71.04 | Sell |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 2.36 | Sell |
| ADX (14) | 14.62 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish. The RSI14 stands at 60, suggesting positive but not extreme momentum. The 50-day simple moving average is $2.30 and the 200-day simple moving average is $2.79, indicating near-term resistance above the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.09 | $2.33 | $3.02 | 0% | Neutral | |
| $1.93 | $2.40 | $3.14 | +3% | Neutral | |
| $2.15 | $2.73 | $3.70 | +17% | Neutral | |
| $2.59 | $3.36 | $4.65 | +44% | Bullish | |
| $2.58 | $3.41 | $4.83 | +46% | Bullish | |
| $2.65 | $3.54 | $5.11 | +52% | Bullish | |
| $2.72 | $3.69 | $5.42 | +59% | Bullish | |
| $2.64 | $3.64 | $5.41 | +56% | Bullish | |
| $3.03 | $4.22 | $6.38 | +81% | Bullish | |
| $3.40 | $4.80 | $7.34 | +106% | Bullish | |
| $4.18 | $6.23 | $10.06 | +167% | Bullish | |
| $6.79 | $11.11 | $19.46 | +377% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.09 | $2.33 | $2.72 | +0.00% |
| June 2026 | $1.98 | $2.32 | $2.78 | -0.35% |
| July 2026 | $2.05 | $2.41 | $2.92 | +3.98% |
| August 2026 | $2.07 | $2.46 | $3.00 | +1.78% |
| September 2026 | $2.03 | $2.42 | $2.98 | -1.53% |
| October 2026 | $2.04 | $2.44 | $3.02 | +0.68% |
| November 2026 | $2.06 | $2.47 | $3.08 | +1.60% |
| December 2026 | $2.00 | $2.41 | $3.02 | -2.64% |
Click any year to see its month-by-month VERU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VERU price prediction for 2026 points to an average of $2.33 (low $2.09, high $3.02) — a potential gain of 0% on today's $2.33. A consolidation phase looks the most probable path here.
In 2027, VERU is projected to trade between $1.93 and $3.14, averaging $2.40 — a potential gain of +3% from today's $2.33. That is up +3% on the projected 2026 average. Price action looks broadly range-bound.
Veru Inc.'s 2028 outlook centres on $2.73, within a $2.15 to $3.70 range. That is up +14% on the projected 2027 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, VERU could reach as high as $4.65, with a base case around $3.36 and support toward $2.59 — roughly +44% from $2.33. Momentum favours further upside here.
Expect VERU to range from $2.58 to $4.83 through 2030. The $3.41 average target implies a +46% move from current prices. That is up +2% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The VERU price prediction for 2031 points to an average of $3.54 (low $2.65, high $5.11) — a potential gain of +52% on today's $2.33. Momentum favours further upside here.
In 2032, VERU is projected to trade between $2.72 and $5.42, averaging $3.69 — a potential gain of +59% from today's $2.33. That is up +4% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Veru Inc.'s 2033 outlook centres on $3.64, within a $2.64 to $5.41 range. That is -2% versus the projected 2032 average. That marks a +56% change versus current levels. Momentum favours further upside here.
By 2034, VERU could reach as high as $6.38, with a base case around $4.22 and support toward $3.03 — roughly +81% from $2.33. Buyers look set to stay in control over this stretch.
Expect VERU to range from $3.40 to $7.34 through 2035. The $4.80 average target implies a +106% move from current prices. That is up +14% on the projected 2034 average. Momentum favours further upside here.
The VERU price prediction for 2040 points to an average of $6.23 (low $4.18, high $10.06) — a potential gain of +167% on today's $2.33. Buyers look set to stay in control over this stretch.
In 2050, VERU is projected to trade between $6.79 and $19.46, averaging $11.11 — a potential gain of +377% from today's $2.33. That is up +78% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VERU today (≈ 429.184549 VERU) could be worth
$4,767.89
+$3,767.89 (+377%) by 2050 · US Dollar
Based on the average projected VERU price of $11.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VERUwould be worth at today's price.
$1,000 invested in VERU on May 27, 2025 (≈ 196.078435 VERU) would be worth
$456.86
-$543.14 (-54.3%) today · 0.46× · US Dollar
Based on a VERU entry price of $5.1 vs. today's $2.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.17 | $1,073.73 | +7.4% |
| 1 month ago | $2.34 | $995.73 | -0.4% |
| 3 months ago | $2.66 | $875.94 | -12.4% |
| 6 months ago | $2.48 | $939.52 | -6.0% |
| 1 year ago | $5.1 | $456.86 | -54.3% |
| All time (5.0y) ago | $88.8 | $26.24 | -97.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VERU forecast.
Our base-case forecast reaches $4.70 around 2035.
Implied market cap at $4.70: $75.44M
The multi-year forecast shows a bullish stance with a clear upward tilt over time. By 2030 the average forecast is $3.46 with a min of $2.60 and a max of $4.95, and an ROI of 47.4. By 2040 the average forecast rises to $6.35 with a min of $4.19 and a max of $10.41, and an ROI of 170.2.
By 2050 the average forecast reaches $11.17 with a min of $6.68 and a max of $19.90, and an ROI of 375.2. These figures portray a trajectory of upside potential across the horizon, with sentiment consistently listed as BULLISH for the later years.
Tap a question to reveal the answer.
2030 forecast shows a min of $2.60, an avg of $3.46, and a max of $4.95, with an ROI of 47.4 and sentiment BULLISH.
Forecasts indicate a bullish long-term trajectory with an average price rising to $3.46 by 2030 and to $11.17 by 2050, and an ROI of up to 375.2, but these are estimates and not guarantees.
Yes. The forecast shows a max of $10.41 by 2040 and a max of $19.90 by 2050, indicating potential to exceed $10 over the long term.
The 2040 forecast implies an avg price of $6.35, with a range from $4.19 to $10.41 and an ROI of 170.2, with sentiment BULLISH.
The 2050 forecast implies an avg price of $11.17, with a range from $6.68 to $19.90 and an ROI of 375.2, with sentiment BULLISH.
Veru Inc. Community Discussion
0Share your Veru Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.